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Does Microbicide Use in Consumer Products Promote
Antimicrobial Resistance? A Critical Review
and Recommendations for a Cohesive Approach
to Risk Assessment
Jean-Yves Maillard,1 Sally Bloomfield,2 Joana Rosado Coelho,3 Phillip Collier,4 Barry Cookson,5
Se´amus Fanning,6 Andrew Hill,7 Philippe Hartemann,8 Andrew J. Mcbain,9 Marco Oggioni,10
Syed Sattar,11 Herbert P. Schweizer,12 and John Threlfall13
The increasing use of microbicides in consumer products is raising concerns related to enhanced microbicide
resistance in bacteria and potential cross resistance to antibiotics. The recently published documents on this topic
from the European Commission have spawned much interest to better understand the true extent of the putative
links for the benefit of the manufacturers, regulators, and consumers alike. This white paper is based on a 2-day
workshop (SEAC-Unilever, Bedford, United Kingdom; June 2012) in the fields of microbicide usage and resis-
tance. It identifies gaps in our knowledge and also makes specific recommendations for harmonization of key
terms and refinement/standardization of methods for testing microbicide resistance to better assess the impact
and possible links with cross resistance to antibiotics. It also calls for a better cohesion in research in this field.
Such information is crucial to developing any risk assessment framework on microbicide use notably in con-
sumer products. The article also identifies key research questions where there are inadequate data, which, if
addressed, could promote improved knowledge and understanding to assess any related risks for consumer and
environmental safety.
Introduction
Microbicides are chemical agents that are com-monly used for the control or destruction of microor-
ganisms in a wide range of applications, including consumer
products and also in the healthcare, food, water, and
manufacturing industries. Such is the extent of their use, that
it is now commonplace to find many products that contain
microbicides (e.g., household cleaning products, toothpastes,
mouthwashes, hand cleaning products, work surfaces, gar-
ments, underwear, pencils, and textiles). Although certain
microbicides have been around for centuries, their use, in
general, saw a decline with the advent of antibiotics. It is
only within the last 60 years or so that the diversity of mi-
crobicides, and the breadth and intensity of microbicidal
usage has increased. Such a revival of interest in microbicide
use is due to mounting antibiotic resistance, emergence/
re-emergence of many infectious diseases as well as changing
life styles and demography,2,29 but also a rise in cleanliness
and hygiene and a better perception of the public issues
around microbial pathogens.16 More recently, outbreaks of
multidrug-resistant bacterial diseases in the healthcare
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settings, increased awareness of the importance of infection
prevention measures, allied to an improved understanding
by consumers of the microbial nature of infectious diseases,
have contributed to the increased usage of microbicides also
in the domestic environment. This rather sudden increase in
microbicide use has prompted questions from the European
Commission as to their contribution to reducing infection
risks and concerns to the possible link(s) between extensive
microbicide use and the emergence of antimicrobial resis-
tance.31 However, it is acknowledged that the main reason
for the worldwide increase in antibiotic resistance is unde-
niably linked to the usage and abuse of antibiotics in human
and veterinary medicine.32 It is, however, difficult to esti-
mate the impact of other contributions such as the use of
biocides or the use of antibiotics in industrial processes.
The past 3 years have seen a limited increase in scientific
output on microbicidal resistance in bacteria to at least begin
to address some of the many deficiencies in our knowledge
gaps as identified by the SCENIHR opinion article.32 Mi-
crobial interactions with, and resistance to, microbicides,
however, continue to remain poorly understood and studied,
when compared to resistance to chemotherapeutic antibiot-
ics. This is compounded by the lack of unity among re-
searchers on what constitutes resistance to a microbicide, as
demonstrated by the variety of definitions and resistance
measurement protocol in the literature, and by the lack of
evidence on the use of microbicides to control the spread of
infections.7
This article is a position document and not an extensive
review of the literature. It provides some key references and
refers to comprehensive reviews such as the one published
by the Scientific Committee for Emerging and Newly Iden-
tified Health31,32 and the Scientific Committee for Consumer
Safety.30
The objectives of this position document are to: (1) clearly
establish and set key definitions of relevant terms, (2) pro-
vide a consensus view on the methods to study changes in
bacterial susceptibility to microbicides, (3) discuss the pos-
sible development of bacterial resistance to microbicides and
antibiotics following their usage, and (4) propose key points
toward developing a risk assessment framework for micro-
bicides in the context of emerging bacterial resistance. This
document will focus only on vegetative bacteria, including
bacterial biofilms.
Toward the Harmonization of Terminology
There is a need to harmonize terminology. The term
‘‘biocide’’ (kills anything living) as currently used, is too
broad and includes, along with disinfectants and antiseptics,
fungicides, algicides, rodenticides, insecticides, and biologi-
cal agents such as bacteriophages and some bacteria (Direc-
tive 98/8/EC).9 This is too broad a meaning when referring
to chemicals that can kill microorganisms and/or inhibit
their replication. Therefore, we recommend the terms ‘‘mi-
crobicide’’ and ‘‘microbistat,’’ respectively, instead of biocide,
which is used in the European Directive in its broader sense.
Thus, microbicides include disinfectants, preservatives, and
antiseptics with activity against bacteria, fungi, spores, pro-
tozoa, cysts, algae, and prions (all microorganisms), but ex-
clude antibiotics. There is also widening acceptance of these
terms in the United States33 and Canada. The terms bacte-
ricide, fungicide etc. should still be used to denote activity
against specific microorganisms.
There is no clear consensus in the scientific community on
the definition of bacterial resistance to microbicides. We
recognize that the definition of ‘‘resistance’’ is key, but this is
far too often subject to different interpretations in the peer-
reviewed literature. Such differences in defining a crucial
term contribute to the difficulty in comparing data and
might, in some cases, communicate the incorrect information
about a microbicide/target bacteria interaction. For example,
resistance has often been used to describe an increased
minimum inhibitory concentration (MIC) to a given micro-
bicide in bacteria, but equally to describe an increase in
minimum bactericidal concentration (MBC) or the survival
of bacteria at an in-use concentration of a microbicide present
in a product.16 We propose that resistance is defined as ‘‘a
change in susceptibility to a microbicide that renders it ineffective
against a micro-organism that was previously susceptible to that
microbicide.’’ This needs to be distinguished from reduced
susceptibility, which refers to the increases in MIC or MBC as
mentioned above, but where microbicides or microbicide-
containing products are still effective for their intended
purpose (at their in-use concentration), that is, inhibition or
destruction of the target microorganism(s), but also from
intrinsic resistance which is an innate property of a micro-
organism. When considering the target microorganism, it is
important to take account of the variability of susceptibility
between strains of the same species (see below).
Information from the literature is often difficult to inter-
pret and compare, because of the lack of consensus defini-
tions and the wide range of laboratory methodologies used
to measure a change in susceptibility or resistance. Thus, the
risk associated with the use of a given microbicide on
the development of microbial resistance is often difficult to
ascertain.
Factors Involved in the Development of Reduced
Susceptibility or Resistance to Microbicides
in Vegetative Bacteria
There are several factors/parameters that can affect the
efficacy of microbicides and these have generally been well
reported.15,31 However, less well reported are the factors that
contribute to the emergence of reduced susceptibility or re-
sistance to microbicides in bacteria. These factors can be di-
vided into three main groups: (1) those that are related to the
microbicide, (2) those inherent to the microorganism, and (3)
those inherent to the biocidal product formulation and its
usage (see Table 1).
Factors related to the microbicide
Microbicides have a wide variety of chemistries. We know
very little of the mechanisms of action of microbicides
against bacteria and the development of microbicide resis-
tance. This is in stark contrast with antibiotics that have
specific target(s) against the bacterial cells and for which, our
understanding of how bacteria may develop resistance
against them is more developed. The best-studied micro-
bicide is the bisphenol triclosan, and to a lesser extent glu-
taraldehyde, the biguanide chlorhexidine, the quaternary
ammonium compounds (QACs) benzalkonium chloride and
cetrimide, chlorinated bisphenols,30,31 hydrogen peroxide,
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and oxygen, and chlorine releasing compounds. Some in-
formation on the mechanisms of action of microbicides may
come indirectly from studies on toxicity against mammalian
cells, for example, the interaction of hydrogen peroxide with
DNA.14 For other microbicides, the information available is
often anecdotal, whereby a specific chemistry has been
studied against one particular type of bacterium or bacterial
enzyme. Information on the modes of action can be obtained
indirectly with determination and knowledge of the con-
centration exponent, which provides some indication of the
nature of the interaction of a microbicide with a specific
bacterium.8 Attempts have rarely been made to determine
the mode of action using radiotracer studies that assess ef-
fects of antimicrobials on DNA, RNA, protein, or cell wall
biosynthesis akin to what is routinely performed to study the
target effects of antibiotics.
Bacteria can survive exposure to microbicides following
a number of strategies (mainly mutation, modification/
degradation of the microbicide, and changes induced by a
stress response) that can occur on their own or together.
Microbicides often have multiple target sites within a given
bacterium and, with this in mind, the development of bac-
terial resistance to microbicides is less likely to arise when
compared to that for most antibiotics, notably the selection
for multiple mutations. The nature (importance) of the target
sites, the number of target sites affected (damaged), and the
degree of damage inflicted by the microbicide, determine
whether the microbicide has a lethal or inhibitory effect. In
terms of resistance, microorganisms are more likely to sur-
vive a microbicide exposure if fewer than a critical number of
sites are damaged.16 This is demonstrated with triclosan (at
sublethal concentrations) for which, a defined target gene
mutation leading to reduced susceptibility to the bisphenol
has been well documented in many bacterial genera and
species. Mutational changes in the enoyl acyl carrier reduc-
tase protein has been linked to a reduced susceptibility to
triclosan in bacteria.12 More recently, a change in the meta-
bolic pathway in Staphylococcus aureus and Salmonella enteric
serovar typhimurium was shown to contribute to reduced
susceptibility to triclosan.34 If an interaction with a specific
target site can be identified, then such an interaction may be
susceptible to mutation, which, if viable, may lead to a re-
sistant or a reduced susceptibility phenotype, as exemplified
with the numerous studies on triclosan.
The importance of the multiple target interaction makes
the development, and genetic transfer, of resistance less
likely.
A given microbicide may become diluted, degraded, or
modified, thus reaching the microbial target in concentra-
tions lower than those applied and required for its effective
action.30 Effective modification/degradation of aldehydes
(e.g., via aldehyde dehydrogenase), metallic salt (through
Table 1. Factors Contributing for the Development of Reduced Susceptibility or Resistance in Bacteria
Examples of microbicide and comments
Factors Potential risk Triclosan Hydrogen peroxide
Inherent to the microbicides
Mechanism of action Primary (single) target site Target enoylACPreductase
at a low concentration
Selection of efflux pump
expressing mutants at low
to high concentrations
Primarily nucleic acid damage
Require penetration in the
bacterial cytoplasm
Concentration Rapid decrease in activity upon
dilution
High-concentration exponent
(rapidly loses activity upon
dilution)
Low-concentration exponent
Formulation Antagonistic effect of excipient
pH incompatibility
Segregation (micelles)
Require solubilizers to attain
high concentration
Rapid loss of activity (product
shelf life?)
Inherent to the bacteriaa
Type Intrinsic resistance Pseudomonas spp. Burkholderia
spp.
Resistant environmental bac-
teria isolated from endo-
scope washer disinfector
Metabolism Low-metabolic activity Reduced activity with low
metabolism
Independent of metabolism
Resistance mechanisms Overexpression
Mutation to constitutive
expression
Efflux Degradation (catalase, super-
oxide dismutase)
Inherent to application
Exposure time Presence of sub-MIC
concentration
Loses rapidly activity upon
dilution
—
Residual concentration Selective pressure No residual concentration
Soiling Reduced bioavailability — Affected by organic matter
(mopping up)
Material/surface Incompatibility
Reduced penetration
Concentration release from
surfaces?
—
aBiofilm and bacterial endospores are not considered in this table.
MIC, minimum inhibitory concentration.
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transformation from the ionic to the metal form), hydrogen
peroxide (e.g., via catalase and super oxide dismutase), and
other microbicides such as biguanide, QACs, and phenolics
have been reported in bacteria.16,31 The rate of such degra-
dation/modification may be too slow (e.g., for phenolics) to
confer resistance when considering the generally short usage
duration of biocidal products. As such, the modification or
degradation of the microbicide may give rise to a reduced
susceptibility phenotype, but not necessarily a resistant
phenotype.16 Long-term microbicide exposure may occur in
the environment, although the effect on the microbial flora
has not been investigated.
The applied concentration of a microbicide, and particu-
larly the concentration reaching the bacterial target site, is
key for activity.16,20 Exposure to a subinhibitory concentra-
tion is likely to exert a selective pressure that will eventually
produce a stress response leading to a change in gene ex-
pression. Such a change, whether transient or permanent,
will lead to the selection for resistant bacteria or bacteria with
a reduced susceptibility.16,31 The effect of dilution on the
efficacy of microbicides can be measured by the concentra-
tion exponent8 and as such, this provides information on the
microbicides at risk (i.e., those with a high-concentration
exponent) of selecting for resistance when diluted or used at
a low concentration; that is, during which, the concentration
would decrease rapidly to an MIC or sub-MIC level. Biocidal
products used at a low concentration for preservation or for
their residual effect on surfaces might thus be particularly
prone to the development of resistance.
Factors related to the microorganisms
Different microorganisms are known to exhibit different
susceptibilities to microbicides. The Spaulding classification
was an excellent approach to rate the susceptibility of mi-
croorganisms to microbicides and is generally still valid, al-
though it has required amending to bring it in line with
current knowledge (Table 2).21 This classification addresses
the intrinsic resistance of microorganisms. Nevertheless,
within specific microbial groups, exceptions exist with re-
gard to the microbicides under consideration.
Microbicides, even at a low concentration, can exert se-
lective pressure on bacteria. This is often evident in the ob-
servation of an extended lag phase of the bacterial growth
curve in the presence of a subinhibitory concentration of that
microbicide.11 Such observations support the concept of an
adaptation time (for example, involving the induction of
specific mechanisms such as efflux, altered outer membrane
protein expression) necessary for the bacteria to respond to
the selective pressure and resume normal growth. Insight
into the underlying mechanisms of adaptation can be pro-
vided through application of techniques such as microarrays,
qRT-PCR, and metabolomic protocols. These have recently
helped in confirming the degree of expression of major reg-
ulators such as RpoS and SoxS, which may eventually lead to
the altered expression of efflux pumps, changes in mem-
brane composition, porin expression, quorum sensing, or
changes in metabolic processes.16,34 How widespread such
genetic responses are in the ability of bacteria to survive and
develop reduced susceptibility or resistance to a microbicide
is unknown. In addition, the induction/adaptation time can
be transient and so translate into an unstable resistance
phenotype; that is, the bacteria revert to susceptibility to that
microbicide when its selective pressure is removed. The ex-
pression of plasmid-encoded resistance mechanisms has of-
ten been described as ‘‘transient.’’ Some bacteria may revert
to a susceptible phenotype following plasmid loss, an indi-
cator that they are losing an un-needed extra genetic burden,
which would otherwise make their growth unfavorable
when the microbicidal selective pressure is removed. Chro-
mosomally encoded resistance mechanisms (e.g., efflux
pumps in Pseudomonas spp.) that are not a burden may be
maintained/transcribed for many, or indeed all, generations
(i.e., they either do not confer an energy burden, or at least
Table 2. Microbial Susceptibility
to Microbicides–Revised Spaulding Classification
Levels of microbicidal action Microbial resistance
High level Prions
Bacterial endospores
Intermediate
level
Protozoal oocysts Unknown
Nonenveloped viruses Expression of resistance
mechanisms
Mycobacteria Adaptation/structure
Protozoal cysts
Fungal spores
Vegetative Gram-negative
bacteria
Expression of resistance
mechanisms
Fungi Unknown
Protozoa (trophozoites) Unknown
Low level Vegetative Gram-positive
bacteria
Expression of resistance
mechanisms
Enveloped viruses
The level of microbicidal action is divided into three levels of activity and it provides information on the susceptibility of
microorganisms. For some microorganisms such as protozoal oocysts and fungi, information is scarce or not available. The effect of
microbicide on the microbial cell or in exerting a selective pressure might alter the classification (indicated with the gray boxes) (arrow
represents a decrease in microbicide susceptibility).
Adapted from McDonnell and Burke.21
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not sufficient to elicit a selective pressure to silence their
expression).
In this context, the emergence of mutator strains has been
associated to antibiotic resistance in general and in particular
to upregulation of efflux pumps, including the accumulation
of compensating mutations, which can reduce potential fit-
ness costs of resistance phenotypes.1,24 Although pertinent to
the use of antibiotics, mutator strains have not been specifi-
cally investigated in response to microbicide exposure. De-
ficiencies in DNA mismatch repair systems or the ability for
a bacterium to acquire exogenous genetic material encoding
for resistance mechanisms (e.g., via conjugative plasmids or
transposons) need to be better understood. Such mechanisms
may contribute to differences in the development of reduced
susceptibility or resistance of different bacterial genera/
species/strains exposed to the same microbicide.
The efficacy of microbicides is affected by the degree of
metabolic activity of the target bacteria; a low metabolic
activity being associated with an ability to survive micro-
bicidal exposure. This may, in turn, contribute to the viable,
but nonculturable (VBNC) state, which might be widespread
following microbicidal exposure. Although the VBNC state
might bemore related to survival and/or induction of damage
repair mechanisms, it might not be a resistance mechanism per
se. However, until more is known, the VBNC state certainly
questions the validity of any protocol to measure bacterial
viability and resistance, following a microbicidal treatment.
Bacterial biofilms, which are widespread in the environ-
ment, add to the number of resistance mechanisms available
to bacteria to survive microbicidal exposure.16 Bacterial
biofilms are less susceptible to microbicides and other anti-
microbials than planktonic bacteria for several reasons, in-
cluding microbicide penetration/quenching, low bacterial
cell metabolism, increased mutability and gene transfer, and
the presence of bacterial cells in a dormant state.10,16
The mechanisms of resistance described above are dis-
cussed in the context of microbicide resistance, and only a
subset of these is relevant to antibiotic resistance (i.e., cross
resistance). Examples of these are shown in Fig. 1 and involve
primarily a decrease in uptake (e.g., changes in membrane
permeability), or an increase in efflux of the antimicrobial
agent. Selective pressure can also result from different resis-
tance determinants occurring in the same mobile genetic ele-
ment (i.e., coresistance), and this may also confer resistance to
antibiotics resulting from microbicide exposure.
Factors related to the usage of microbicides
Overall, there is little information as to how the conditions
of use of biocidal products may affect bacterial reduced sus-
ceptibility or resistance. This is partly because parameters
in situ might be difficult to measure, or are simply not re-
corded. Such information is critical for the end-users, manu-
facturers, and regulators. Factors that drive a decrease in the
concentration of a microbicide to levels close to the MIC
will be conducive to changes in a bacterial genotype and
phenotype.
Parameters, such as actual exposure time, actual residual
concentration over time, frequency of application, dilution
on application, amount and type of soiling (exogenous or-
ganic material) present, which impact on concentration and
bioavailability, will have an effect on microbicidal efficacy at
application; that is, the level of bacterial survival to be ex-
pected (Table 1). The nature of the surface (i.e., porous,
nonporous) treated will also have an effect on the efficacy of
a microbicide. The effect of soiling in decreasing the activity
of certain microbicides has been well documented.28
For certain biocidal products, where the microbicide is
embedded in the product, bioavailability of the microbicide
is paramount and, as such, the concentration release from the
products should be known.
Biocidal products are, in general, complex formulations,
which, quite apart from containing one or more micro-
bicides, can also have a number of excipients/adjuncts. Such
excipients can potentiate the activity of the microbicide or
have some antimicrobial activity per se and can comprise
surfactant, fragrance wetting or chelating agents. There is
little available information on the effect of these different
excipients in combination with the microbicide(s) on the ef-
ficacy of the biocidal products, although some combinations
FIG. 1. Mechanisms leading to bacterial resistance and cross resistance to microbicides and unrelated antimicrobials.
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such as chlorhexidine with alcohol or QACs with ethylene
diamine tetra acetic acid (EDTA), a chelating agent, have
been shown to be synergistic. Generally, the formulation of
the biocidal product is not considered when testing for evi-
dence of reduced susceptibility or resistance in bacteria. This
should be addressed, since this reflects the actual use of
products and formulations should be tested alongside a
microbicide.16,31,32
The Need for Harmonization of Methodologies
to Study Bacterial Reduced Susceptibility
and Resistance to Microbicides
Current methodologies
Methodologies used to measure a change in susceptibility
to a microbicide and whether in situ studies provide better
information than in vitro studies have been the subject of
considerable debate. The protocol most often used in peer-
reviewed publications is the determination of the MIC. Al-
though such a protocol, particularly the use of amicrodilution
method, enables rapid susceptibility screening of target bac-
teria, a change in MIC is not necessarily an indicator of bac-
terial resistance to a microbicide, but merely an indication of
the propensity of a microbicide to alter the bacterial pheno-
type.16,27 The use of the MBC, or for biofilms, the minimum
biofilm eradication concentration, may be more appropriate,
as this reflects the lethal nature of a microbicide.3,25 MBC
protocols are more complex than MIC protocols, as they re-
quire the neutralization of the microbicide, but such protocols
can also be reformatted to accommodate high throughput.
The use of inactivation kinetics to understand the rate-of-kill
with time provides additional information on the interaction
between a microbicide and the target bacteria. The shape of
the inactivation curve, in particular, can provide potential
information as to the presence of bacterial subpopulations
that may be less susceptible to amicrobicide.16 The generation
of data describing a kill-curve is laborious and can only
be reasonably applied to investigate a limited number of
bacteria/microbicide concentration combinations. The use of
newer protocols such as flow cytometric analysismay provide
a higher throughput methodology to investigate the behavior
of single strains (and the presence of subpopulations) exposed
to a microbicide35 and provide further insight into the nature
of the bacterial response.
A major advantage of in vitro experiments is that the test
parameters can be controlled accurately to produce repro-
ducible data sets. Unfortunately, parameters such as tem-
perature, contact time, concentration, and the preparation of
test inocula—growth media and diluents used, bacterial
metabolism at the time of testing, vary widely between
studies and this results in poor levels of comparability be-
tween them.
There have been only a limited number of in situ studies
investigating the effect of microbicide (biocidal products)
usage on emerging bacterial resistance. These studies have
produced conflicting information on the effect of a micro-
bicide on bacterial community susceptibility to microbicides
or antibiotics following application of antibacterial products,
at the point of use.4,6,17 Although these studies are very
valuable and provide realistic information, researchers have
to often set their own susceptibility/resistance criteria to
facilitate the interpretation and significance of results, mak-
ing comparisons between studies more difficult. In addition,
because of their nature, in situ studies tend to be less re-
producible and more costly than in vitro investigations.
Toward a consensus in methodologies
Both in vitro and in situ studies are valuable in their own
right, but have also suffered from many drawbacks. If in situ
investigations may be considered as an ultimate validation,
in vitro protocols provide a proof-of-concept reproducibility
and confidence in results. In vitro protocols must be im-
proved for their results to be more meaningful (Table 3). The
use of environmental isolates, together with parameters re-
flecting conditions of exposure in vivo are paramount.16
Ciusa et al.5 established a baseline susceptibility profile of
1388 S. aureus isolates to triclosan and showed that envi-
ronmental isolates presented different mutations to culture
collection isolates. This type of information (i.e., distribution
of susceptibility to a microbicide of a population of the target
microorganism) should ideally be considered as part of
in vitro protocols. Such data are necessary to establish cutoff
values for a given bacterium–microbicide combination,
which could serve as reference points (e.g., for risk assess-
ment of microbicide resistance),5 in analogy to the definition
of epidemiological cutoff (ECOFF) values of antimicrobial
susceptibility.13 In contrast to the ECOFF concept, which is
based on wild-type MIC distributions, the microbicide cutoff
values should consider both MIC and MBC distributions,
and take account of the differences between such distribu-
tions from environmental isolates and those from culture
collection strains.
There are a number of studies focusing on the use of en-
vironmental isolates alongside standard strains obtained
from culture collections. We propose that these types of in-
vestigation, combining environmental isolates and in situ test
conditions should be termed ex situ (i.e., realism-based
studies), represent the experimental conditions better.
The study of complex microcosms (i.e., communities
of microorganisms) is more challenging, but can provide
valuable information, notably on the effect of a microbicide
in changing the composition of a complex microcosm. A
small number of studies18,19,23 in which, complex micro-
cosms were investigated ex situ provide excellent examples
of the usefulness of such investigations, highlighting the
alterations in the microcosm composition as well as suscep-
tibilities to microbicides.
Potential for predictive methodologies
Studies that investigate changes in reduced susceptibility
or increased resistance to a given microbicide should ulti-
mately aim to determine if there is a risk of microbial resis-
tance development associated with the usage of a specific
microbicide. Studies reported in the literature are not de-
signed to predict the risk of microbial resistance develop-
ment and merely report a susceptibility profile with, or
without, associated putative mechanism(s) of resistance.
Predictive studies have been hampered by the nature of
microbicide interaction with the microbial cells (i.e., multiple
target sites) and the different responses that can be expected
when investigating, for example, different bacterial species.
The complexity of providing a risk-based approach does not
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mean that the development of such a protocol is unrealistic.
Measuring the change in susceptibility profile following a
realistic exposure to a given microbicide or biocidal product
can yield important information, and provide a risk estimate,
or at least a prediction of the risk, associated with the use of a
microbicide; this implies that the test inoculum, its nature and
metabolic status, is strictly controlled and that the suscepti-
bility profile (MIC/MBC) of the test bacterium to a micro-
bicide and other antimicrobials is established and shown to
be reproducible (Fig. 2). When a reproducible change in
susceptibility is recorded, further tests to understand the
nature of the change, whether it is transient or permanent, the
mechanisms associated with the change, and a comparison
with the susceptibility profile of environmental isolates can
be performed. Two essential criteria for establishing such a
protocol are that the test needs to allow for high throughput
and that it needs to use realistic in situ parameters that reflect
actual conditions during use of the product.
Toward the Development of a Risk Assessment
Framework for Microbicide Resistance
The establishment of a risk assessment framework for mi-
crobicide resistance is key for the industry and regulators.
Such a framework would provide confidence that the use of
biocidal products is safe so far as emerging microbial reduced
susceptibility or resistance is concerned. To date, most risk
assessments applied in the area of antimicrobial resistance
have considered the risk posed by the use of antibiotics in
veterinary medicine.22 However, for microbicides, there is
much less known about the factors associated with the prob-
ability of resistance and cross-resistance development, and
how these should be considered in risk assessment. In the area
of antibiotic resistance in veterinary medicine, current attempts
to conduct risk assessments are hampered by the lack of a
consensus definition of antibiotic resistance and a lack of sci-
entific data; the development of a risk assessment framework
for microbicide resistance development faces similar issues.
The development of semi- or fully quantitative risk as-
sessments on bacterial resistance to microbicides is therefore
some distance away and relies on the production of appro-
priate data (Fig. 3), preferably standardized and working to a
widely accepted definition. Focusing on the probability of
resistance development only, as opposed to assessing the
absolute human health risk, is a more realistic ambition in
the near future. This can be considered akin to the entry
assessment stage of the OIE risk assessment framework.26 An
example of a theoretical framework for resistance develop-
ment is given in Fig. 3. The probability of generating resis-
tant or reduced-susceptibility strains, given a microbicide
Table 3. Relevance of In Vitro Studies to Applications In Situ
In vitro investigation Aims
Relevance to applications
in practice Comments
Stepwise training Reduced susceptibility by
passaging in increasing
concentration of
microbicide
Does not reflect bacterial expo-
sure to a microbicide
Not useful to predict a risk
associated with microbicide
usage
Exposure to a high
concentration
Exposure of a high inoculum
to in use concentrations
Does not yield many resistant
bacteria
Presence of high inoculum con-
centration unlikely except for
biofilm
Unrealistic to predict a risk
associated with microbicide
usage
Exposure to active
ingredient alone
Understand the effect of
the active on emerging
resistance
Formulations are used in
practice
Formulations can increase or
decrease the activity of the
main ingredient
Formulation excipients may
have intrinsic activity
Only provide information on the
microbicide and might not be
relevant with the biocidal
product
Use of MIC Provide an indication of
possible changes in suscep-
tibility and subsequent
resistance
Exposure to an inhibitory
concentration
High lethal concentrations are
used in practice (in most
applications)
Allow for high-throughput
screening, but not as relevant
as measuring MBC
Exposure to low
subinhibitory
concentrations
Induction of resistance
Study of cross resistance and
coresistance
Reflect usage of a low concen-
tration of a biocide (including
leaching and residual activi-
ty) and reduced bioavailabil-
ity (certain biocidal products
and applications)
Relevant for many current ap-
plications and provide infor-
mation on a threshold
concentration associated with
emerging reduced suscepti-
bility and resistance
Use of a laboratory
test strain
Allow the work to be
reproduced in different
laboratories
Environmental isolates might not
show the same susceptibility
profile and resistance mecha-
nisms
The use of environmental iso-
lates is more relevant, but
they need to be available to
test laboratories
Adapted from Maillard and Denyer.16
MBC, minimum bactericidal concentration.
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FIG. 3. Theoretical risk assessment pathway approach for microbicide resistance. This figure illustrates a potential theo-
retical pathway to assist in estimating the probability of emerging microbicide resistance for a specific bacteria/microbicide
combination, by following the number of susceptible (S) and microbicide resistant (R) from initial application (S= S0 and
R =R0) over the course of microbicide application and decay. How resistance does or does not emerge is determined by
whether the concentration of the microbicide at any point in time is above or below the MIC and/or minimum bactericidal
concentration (MBC). The difference between transient resistance (S’) and established resistance (R) is recognized.
FIG. 2. Example of a flow through method to measure change in bacterial susceptibility profile to microbicides and other
antimicrobials.
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concentration of B, P(RjB), depends on the concentration of
the microbicide, and whether that concentration is (1) suffi-
cient to facilitate mutations that may confer resistance char-
acteristics or (2) sufficient to inactivate all susceptible
organisms and, hence, confer a selective advantage to in-
trinsically resistant organisms. The concentration B is de-
pendent on the initial concentration of application, B0, and
the decay rate of the microbicide activity over time. The
probability of producing a resistant or reduced-susceptibility
population of bacteria, P(RjB), can be defined as the com-
bined probability of selecting intrinsically resistant strains,
P(resjB), and the probability of inducing transient resistance,
P(indjB), that is, P(RjB) =P(resjB) +P(indjB). Different scenar-
ios may arise depending on the concentration of the micro-
bicide as illustrated in Fig. 3.
The probabilities of selection and induction (i.e., of the ex-
pression of resistance mechanism(s)) are dependent on
the concentration of the microbicide, and will change as the
concentration of the microbicide changes over time. Prob-
abilities for resistance selection will be dependent on the
active concentration of the microbicide, the relevant MIC
and MBC, and the ratio of resistance to susceptible organisms
in the target population of number N. The probability of
inducing transient resistance will be dependent on the num-
bers of susceptible bacteria, S, and the adaptation or mutation
rate in the presence of microbicide at concentration B.
To consider the probability of developing cross resistance
to antibiotics, the theoretical risk assessment pathway shown
in Fig. 3 could be used, but the mechanisms responsible for
induction or selection should be known and relevant to an-
tibiotic resistance (e.g., efflux or changes in membrane per-
meability), as discussed above. This schematic could also
be adapted to consider coresistance by introducing an
additional step (i.e., following induction or selection) that
involves exposure to an antibiotic, but in this case, this is
dependent on the resistance determinants (for both micro-
bicide and antibiotic) being colocated on the same mobile
genetic element.
Of course, there are many other factors that are impor-
tant to consider in any safety assessment for biocidal pro-
duct approval, of which, the potential for development of
microbicide resistance is only one. However, there is con-
siderable value in trying to identify the risk factors involved
in selection and/or induction of microbicide resistance un-
der conditions of use of biocidal products. The suggested
framework is a proposal from a group of experts to describe
the salient pathways for microbicide resistance and high-
light some of the crucial data requirements (e.g., MIC/
MBCs of biocide and concentrations of biocide in relevant
environments over time). As such, it provides a proposal for
the inclusion of such factors and approaches into estab-
lished processes of any human health risk assessments for
safety assurance.
Another possible option for risk assessment in the short
term would be to outline a qualitative approach for risk
prioritization such as risk ranking of microbicides in terms of
their likelihood to induce or select for bacteria with de-
creased susceptibility (possibly based on criteria layout in
Table 1). Risk ranking along these lines might be appropriate
and achievable for a limited number of microbicides on the
basis of our current knowledge, and would be useful to in-
form risk management.
A Way Forward for Microbicidal Research
This position document has reflected on current research
and available data and makes a number of key research
recommendations.
Harmonization of terms and methods
Global harmonization is a key requirement, particularly
on the protocols used to measure changes in susceptibility
and mode(s) of action. Microbicide research is at present
disparate and data generated are difficult to compare. We
recommend the use of parameters that reflect better the
conditions found in practice, and with this in mind, the use
of ex situ protocols are more appropriate.
We recommend that initiatives are progressed to encour-
age global harmonization of protocols used to measure
changes in susceptibility and mode(s) of action. Such
protocols should consider parameters that reflect better
conditions found in practice, including the use of more ap-
propriate ex situ protocols. This will enable research and
other studies to be better compared.
Generating baseline susceptibility information
The use of culture collection standard strains might not
reflect the behavior of environmental bacteria. The use of
environmental isolates is thus recommended (ex situ proto-
col). Ideally, the susceptibility of a large number of envi-
ronmental isolates (same genus, species) to microbicides
should be determined to provide background information on
a specific bacterial genera/species. This information should
be made globally available.
Understanding bacterial resistance and dissemination
There is a paucity of information on the interaction(s) of
microbicides (notably at a low concentration) with the bac-
terial cells. The most studied microbicide is triclosan, but this
is an exception. Other microbicides, notably those used in
preservative systems (e.g., isothiazolinones, pyrithiones)
have shown an ability to allow the development of reduced
susceptibility/resistance in selected bacteria and yet these
mechanisms are poorly understood. There has been an
increase in omic studies to understand better the genetic
mechanisms of resistance. Such investigations should be
encouraged, alongside more traditional methods. The dis-
semination and maintenance of mobile genetic elements
should be better investigated, as this presents an important
risk factor for emerging bacterial resistance to unrelated
compounds, including therapeutic antibiotics.
Biofilms
The study of biofilms, including complex biofilms, is a
challenge, although they may better represent certain envi-
ronmental and clinical settings. Laboratory studies based on
environmental biofilms grown in fermentors using realistic
environmental parameters (ex situ) should be encouraged.
Education and data mining
Microbicides are an important resource that needs to be
well managed to preserve their efficacy. A better under-
standing of their conditions of use and consumer habit
is necessary to establish reflective ex situ studies and,
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ultimately, predict the risk associated with a particular mi-
crobicide and its application. This also means that both end
users and industry need to gain a better understanding on
the appropriate use of microbicide and the risks associated
with the misuse of biocidal products.
Conclusions
Among the different hygiene measures, those dealing with
antisepsis and disinfection are recognized as a cost-effective
means to reduce the infectious disease burden. Microbicides
have a vital role in preventing infectious disease transmission
in the home, but they should not be used indiscriminately and
a risk-based (targeted) approach to hygiene should be re-
commended.2 One has to bear in mind that the inappropriate
and overuse of microbicides might also have a detrimental
effect on human health and the environment. The inclusion of
microbicides in products and product claims (e.g., bactericidal
action) should be carefully reassessed and should not solely
serve a commercial purpose, but as a need for microbial-
control/prevention. Thus, education about how microbicides
are useful in a domestic environment is very important.
This position document calls for harmonization of defini-
tion and methodology to unite microbicidal research. A
number of definitions have been proposed reflecting on the
use of specific protocols to assess changes in bacterial sus-
ceptibility when exposed to a microbicide. A realistic risk
assessment framework is essential for assessing the impli-
cations of microbicide use, for both the industry and the
consumer (end user) and regulators.
Hopefully, this position document will encourage scien-
tists in the field of microbicide research to move toward
developing a unified risk-based approach to microbicide
production and the subsequent use of such products in the
industry, hospitals, and home.
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